Anuradha Acharya is the CEO, Mapmygenome. She is currently serving as a governing board member at Council for Scientific and Industrial Research (CSIR). While speaking with The wp Journal, she expressed the need to increase awareness about health and medical issues amongst employees. Taking into consideration the health scenario of the nation, which carries 20% of the world’s burden of TB patients; she suggests how corporate funding for low cost affordable medicines can be a good start. Anuradha has also received the ” Young Global Leader” award by the World Economic Forum.
When you work for the larger good, you’re doing good for yourself too: Anuradha Acharya
Related Articles
CSR News: Kotak Mahindra Bank Supports Advanced Diagnostic Facility at SMIMER Hospital, Surat
Surat, India: Kotak Mahindra Bank Limited, under its CSR initiative, has extended support to the Surat Municipal Institute of Medical Education and Research (SMIMER)...
Cancer Treatment: कैंसर इलाज में क्रांति ला सकता है नया AI Cancer Tool ‘AA-Net’, हर कोशिका की पहचान कर सकेगा सटीक उपचार
Cancer Treatment जंग में एआई बना नया हथियार, इलाज में आएगा क्रांतिकारी बदलाव
कैंसर जैसी जानलेवा बीमारी के इलाज में अब आर्टिफिशियल इंटेलिजेंस (AI) बड़ी...
Drone Delivery of Medicine in North East: अरुणाचल प्रदेश में शुरू हुई ड्रोन डिलीवरी, अब पहाड़ों तक पहुंचेंगी जरूरी दवाएं और अंग
आपात स्थितियों में होगी दवाओं और मानव अंगों की तेज डिलीवरी
Drone Delivery of Medicine in North East: पूर्वोत्तर भारत के दुर्गम पहाड़ी इलाकों में...